×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Institute of Chi... [2]
THE STATE KEY LA... [2]
Authors
CHEN MEIWAN [1]
YU HUA [1]
Document Type
Journal article [1]
Review article [1]
Date Issued
2024 [1]
2022 [1]
Language
英語English [2]
Source Publication
Advanced Materia... [1]
Frontiers in Pha... [1]
Indexed By
SCIE [2]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-2 of 2
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
GSH/pH Dual Activatable Cross-linked and Fluorinated PEI for Cancer Gene Therapy Through Endogenous Iron De-Hijacking and in Situ ROS Amplification
Journal article
Yang, Suleixin, Wu, Yi, Zhong, Wenzhao, Chen, Ruie, Wang, Meilin, Chen, Meiwan. GSH/pH Dual Activatable Cross-linked and Fluorinated PEI for Cancer Gene Therapy Through Endogenous Iron De-Hijacking and in Situ ROS Amplification[J]. Advanced Materials, 2024, 36(2).
Authors:
Yang, Suleixin
;
Wu, Yi
;
Zhong, Wenzhao
;
Chen, Ruie
;
Wang, Meilin
; et al.
Favorite
|
TC[WOS]:
24
TC[Scopus]:
22
IF:
27.4
/
30.2
|
Submit date:2024/02/22
Cancer Gene Therapy
Endogenous Iron De-hijacking
Ferroptosis
Lipid Peroxide
Mitochondria Damage
Reactive Oxygen Species
A Novel Anti-Cancer Therapy: CRISPR/Cas9 Gene Editing
Review article
2022
Authors:
Xin-Zhu Chen
;
Rong Guo
;
Cong Zhao
;
Jing Xu
;
Hang Song
; et al.
Favorite
|
TC[WOS]:
11
TC[Scopus]:
13
IF:
4.4
/
5.0
|
Submit date:2023/01/30
Anti-cancer Therapy
Crispr/cas9
Ethics
Gene Editing Technology
Off-target Effect